Benjamin Chua

The University of Queensland

Papers

1

Total Citations

6

H-Index

1

About

Dr. Benjamin Chua is a leading head and neck surgical oncologist whose research centers on refining treatment paradigms for oropharyngeal squamous cell carcinoma (OPSCC), with a particular focus on de-escalation strategies and functional preservation. His most cited work, a 2019 prospective study on primary transoral robotic surgery (TORS) for early tonsillar cancer, established a risk-adapted approach to adjuvant radiotherapy—demonstrating that carefully selected patients could avoid the morbidity of combined-modality treatment while maintaining excellent oncologic control. This landmark paper, with 6 citations, has influenced clinical guidelines for organ-preserving surgery. Beyond this, Dr. Chua’s broader contributions include advancing patient selection criteria for unimodality TORS, optimizing perioperative protocols, and investigating quality-of-life outcomes in head and neck cancer survivors. His work bridges the gap between surgical innovation and evidence-based de-escalation, directly impacting how early-stage OPSCC is managed worldwide. A sought-after collaborator and educator, Dr. Chua continues to shape the field through prospective trials and multidisciplinary care models, making him a pivotal figure in modern head and neck oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes of primary trans-oral surgical management of early tonsillar squamous cell carcinoma with risk-adapted adjuvant radiotherapy
6 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: The University of Queensland

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago